| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 71.1159 | 69 |
| GSM780708 | Untreated after 4 days (C2_1) | 66.2574 | 68 |
| GSM780709 | Untreated after 4 days (C3_1) | 86.5965 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 69.1481 | 69 |
| GSM780720 | Untreated after 4 days (C2_2) | 66.7941 | 68 |
| GSM780721 | Untreated after 4 days (C3_2) | 74.3132 | 70 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 70.7644 | 69 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 69.1988 | 69 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 64.8487 | 67 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 68.6225 | 69 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 61.8587 | 66 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 66.4504 | 68 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 69.1351 | 69 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 58.641 | 63 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 59.2667 | 64 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 75.4251 | 71 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 69.6255 | 69 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 67.8204 | 68 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 55.0947 | 60 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 75.4463 | 71 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 63.6435 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 70.1324 | 69 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 72.2279 | 70 |